Nagarjun Ayurvedic Center

Details

Name :

Nagarjun Ayurvedic Center

Address  :

Kalayanthani
Thodupuzha

Town  :

Thodupuzha

State  :

Kerala

Country  :

INDIA

Post Code:

685 588

Phone  :

91 486 2276112

Fax  :

91 486 2276923

Web URL  :

Facilities

Speciality Type :

  • Single Speciality : Ayurvedic

Other Mode Of Therapies

  • Yoga
  • Homopathy
  • Ayurvedic

Description

NAGARJUNAs fullfledged Ayurvedic Centre located on the banks of the river Periyar at Kalady in Kerala provides a complete range of Ayurvedic Treatments strictly conforming to the traditional practices Kalady is world renowned as the birthplace of the great Indian Philosopher Sankaracharya and where the vibrations of the past are still felt The place provides the right ambiance for a suitable sojourn in harmony with nature and is a civilization apart from Modern Life Set in the lap of scenic nature the sacred place exudes serenity and sanctity instilling divine and spiritual thoughts into ones mind
The surrounding landscape and the aesthetically designed rooms with all amenities stimulate the inmates to rediscover life in its entirety Realizing the mystical curative powers of Ayurveda the centre is today a much soughtafter destination for people from world over who seek a better way of life Nagarjuna Ayurvedic Centre blends deep ayurvedic insights with traditional skills to provide a range of remedies based on preventive curative rejuvanative and immunization therapies


History

The center founded in the year 1996 has an expert panel of Ayurvedic doctors headed by Dr Krishnan Namboodhiri the chief physician who is the undisputed guru in ayurvedic treatments in Kerala
Goodwill Hospital refiles DRHP to raise Rs 98 cr via IPO

Goodwill Hospital and Research Centre which withdrew its IPO in January this year due to poor investor response has again filed draft papers with market regulator Sebi for the public issue The healthcare firm said it is considering a preIPO placement for a cash consideration of Rs 30 crore according to the Draft Red Herring Prospectus DRHP filed... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More